Heterocyclic compounds as kinase inhibitors

• 收藏
• 分享

专利权人:

ORIGENIS GMBH

发明人:

ALMSTETTER MICHAEL,TREML ANDREAS,KOESTLER RONALD

申请号：

AP2013007252

公开号：

AP2013007252A0

申请日:

2012.04.23

申请国别(地区):

AP

年份:

2013

代理人:

摘要：

The present invention relates to novel compounds of formula (I) that are capable of inhibiting one or more kinases, especially SYK (Spleen Tyrosine Kinase), LRRK2 (Leucine-rich repeat kinase 2) and/or MYLK (Myosin light chain kinase) or mutants thereof. The compounds find applications in the treatment of a variety of diseases.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/